CHRS logo

Coherus Oncology, Inc. (CHRS)

Profile

Full Name

Coherus Oncology, Inc.

Ticker

NASDAQ: CHRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 6, 2014

Indexes

Not included

Website

http://www.coherus.com

Employees

221

Key Details

Price

$1.04(+1.96%)

Market cap

$120.57M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$266.96M(+3.78% YoY)

Annual EPS

$0.25(+109.88% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.04
    CHRS price is $1.04

    30-Day Relative Volume

    1.57
    CHRS 30-day relative volume is 1.57

    Price Performance

    Price Most recent change

    +1.96%
    CHRS price was up +1.96% on Jul 25, 2025

    Price YTD change

    -24.64%
    CHRS price is down -24.64% since January 1st

    Price 1-year change

    -39.53%
    CHRS price is down -39.53% year-on-year

    Price 3-year change

    -87.68%
    CHRS price is down -87.68% over the past 3 years

    Price Range

    Price All-time high

    $38.10
    CHRS price is currently -97.27% below its historical high of $38.10

    Price 3-year low

    $0.66
    CHRS price is currently +57.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $120.57M
    CHRS market capitalization is $120.57 million

    Market cap 3-year change

    -81.62%
    CHRS market capitalization is down -81.62% over the past 3 years

    Market cap All-time high

    $1.63B
    CHRS market capitalization is currently -92.59% below its historical high of $1.63 billion

    Market cap sector rank

    44.68%
    CHRS market capitalization is higher than 44.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.64%
    CHRS shares outstanding is up +0.64% year-on-year

    Shares Outstanding 3-Year Change

    +49.2%
    CHRS shares outstanding is up +49.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.38
    CHRS beta is 1.38

    200-day SMA

    $1.03
    CHRS price is currently +0.91% above its 200-day simple moving average

    50-day SMA

    $0.81
    CHRS price is currently +27.64% above its 50-day simple moving average

    RSI

    68.86
    CHRS 14-day relative strength index is 68.86

    Volume

    1.57
    CHRS 30-day relative volume is 1.57

    ATR

    $0.06
    CHRS average true range is $0.06

    10-day Historical Volatility

    84.98%
    CHRS 10-day historical volatility is 84.98%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $266.96M
    CHRS annual revenue is $266.96 million

    Revenue Analysts estimate

    $48.35M
    CHRS annual revenue is currently +452.13% higher than the consensus analysts' forecast

    Revenue 1-year change

    +3.78%
    CHRS annual revenue is up +3.78% year-on-year

    Revenue Sector rank

    67.09%
    CHRS annual revenue is higher than 67.09% of companies in Healthcare sector

    EPS

    EPS

    $0.25
    CHRS annual earnings per share is $0.25

    EPS Analysts estimate

    -$1.05
    CHRS annual earnings per share is currently -123.78% lower than the consensus analysts' forecast

    EPS 1-year change

    +109.88%
    CHRS annual earnings per share is up +109.88% year-on-year

    EPS Sector rank

    85.15%
    CHRS annual earnings per share is higher than 85.15% of companies in Healthcare sector

    Profit

    Gross profit

    $149.41M
    CHRS annual gross profit is $149.41 million

    Gross margin

    55.97%
    CHRS annual gross profit margin is 55.97%

    Operating profit

    -$111.67M
    CHRS annual operating income is -$111.67 million

    Operating margin

    -41.83%
    CHRS annual operating profit margin is -41.83%

    Net income

    $28.51M
    CHRS annual net profit is $28.51 million

    Net margin

    10.68%
    CHRS annual net profit margin is 10.68%

    Expenses

    Total expenses

    $378.63M
    CHRS annual total expenses is $378.63 million

    Operating expenses

    $261.07M
    CHRS annual total operating expenses is $261.07 million

    Cost of goods sold

    $117.55M
    CHRS annual cost of goods sold is $117.55 million

    Selling, general & administrative expenses

    $167.74M
    CHRS annual SGA is $167.74 million

    Depreciation and amortization

    $5.28M
    CHRS annual depreciation & amortization is $5.28 million

    Interest expense

    $27.16M
    CHRS annual interest expense is $27.16 million

    Income tax

    $0.00
    CHRS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    $55.66M
    CHRS annual earnings before interest & taxes is $55.66 million

    EBITDA

    $55.66M
    CHRS annual EBITDA is $55.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $448.53M
    CHRS annual total assets is $448.53 million

    Non current assets

    $53.65M
    CHRS annual long term assets is $53.65 million

    Current assets

    $351.18M
    CHRS annual total current assets is $351.18 million

    Cash and cash equivalents

    $125.99M
    CHRS annual cash & cash equivalents is $125.99 million

    Accounts receivable

    $111.32M
    CHRS annual accounts receivable is $111.32 million

    Inventory

    $70.09M
    CHRS annual inventory is $70.09 million

    Liabilities

    Total liabilities

    $580.52M
    CHRS annual total liabilities is $580.52 million

    Long term liabilities

    $297.54M
    CHRS annual total long term liabilities is $297.54 million

    Current liabilities

    $164.87M
    CHRS annual total current liabilities is $164.87 million

    Accounts payable

    $28.46M
    CHRS annual accounts payable is $28.46 million

    Debt

    Total debt

    $269.90M
    CHRS annual total debt is $269.90 million

    Total debt 1-year change

    -43.87%
    CHRS annual total debt is down -43.87% year-on-year

    Long term debt

    $268.21M
    CHRS annual long term debt is $268.21 million

    Short term debt

    $1.69M
    CHRS annual short term debt is $1.69 million

    Equity & Capital

    Shareholders equity

    -$131.99M
    CHRS annual stockholders equity is -$131.99 million

    Book value

    -$131.99M
    CHRS annual book value is -$131.99 million

    Retained earnings

    -$1.55B
    CHRS annual retained earnings is -$1.55 billion

    Working capital

    $186.31M
    CHRS annual working capital is $186.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$20.44M
    CHRS annual cash flow from operations is -$20.44 million

    Cash from operations 1-year change

    +88.31%
    CHRS annual cash flow from operations is up +88.31% year-on-year

    Cash from investing

    $230.32M
    CHRS annual cash flow from investing activities is $230.32 million

    Cash from investing 1-year change

    +59.24%
    CHRS annual cash flow from investing activities is up +59.24% year-on-year

    Cash from financing

    -$186.97M
    CHRS annual cash flow from financing activities is -$186.97 million

    Cash from financing 1-year change

    -368.64%
    CHRS annual cash flow from financing activities is down -368.64% year-on-year

    CAPEX

    CAPEX

    -
    CHRS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CHRS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$20.44M
    CHRS annual free cash flow is -$20.44 million

    Free cash flow 1-year change

    +88.33%
    CHRS annual free cash flow is up +88.33% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    55.97%
    CHRS annual gross profit margin is 55.97%

    Operating margin

    -41.83%
    CHRS annual operating profit margin is -41.83%

    Net margin

    10.68%
    CHRS annual net profit margin is 10.68%

    ROA & ROE

    ROA

    5.29%
    CHRS annual return on assets is 5.29%

    ROE

    -21.60%
    CHRS annual return on equity is -21.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CHRS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CHRS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.66
    CHRS price to book ratio is -0.66

    PB ratio Sector rank

    10.67%
    CHRS price to book ratio is higher than 10.67% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.61
    CHRS price to sales ratio is 0.61

    PS ratio Sector rank

    15.73%
    CHRS price to sales ratio is higher than 15.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $308.09M
    CHRS enterprise value is $308.09 million

    Enterprise value Sector rank

    58.55%
    CHRS enterprise value is higher than 58.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.12
    CHRS EV/EBITDA is -3.12

    EV/EBITDA Sector rank

    33.63%
    CHRS EV/EBITDA is higher than 33.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.13
    CHRS annual current ratio is 2.13

    Quick ratio

    1.70
    CHRS annual quick ratio is 1.70

    Leverage

    Debt to equity

    0.00
    CHRS annual debt to equity ratio is 0.00

    Interest coverage ratio

    2.05
    CHRS annual interest coverage ratio is 2.05

    Risk & Stability

    Piotroski F-Score

    6
    CHRS piotroski f-score is 6

    Altman Z-Score

    -3.21
    CHRS altman z-score is -3.21

    Analyst ratings

    Recent major analysts updates

    Apr 29, 25 HC Wainwright & Co.
    Buy
    Apr 24, 25 UBS
    Neutral
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Jan 23, 25 HC Wainwright & Co.
    Buy
    Jan 22, 25 HC Wainwright & Co.
    Buy
    Dec 5, 24 Baird
    Outperform
    Dec 4, 24 HC Wainwright & Co.
    Buy
    Nov 8, 24 Baird
    Outperform
    Nov 7, 24 HC Wainwright & Co.
    Buy
    Sep 16, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CHRS included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Coherus Oncology, Inc.?
    • Does Coherus Oncology, Inc. pay dividends?
    • What sector is Coherus Oncology, Inc. in?
    • What industry is Coherus Oncology, Inc. in?
    • What country is Coherus Oncology, Inc. based in?
    • When did Coherus Oncology, Inc. go public?
    • Is Coherus Oncology, Inc. in the S&P 500?
    • Is Coherus Oncology, Inc. in the NASDAQ 100?
    • Is Coherus Oncology, Inc. in the Dow Jones?
    • When was Coherus Oncology, Inc.'s last earnings report?
    • When does Coherus Oncology, Inc. report earnings?

    What is the ticker symbol for Coherus Oncology, Inc.?

    The ticker symbol for Coherus Oncology, Inc. is NASDAQ:CHRS

    Does Coherus Oncology, Inc. pay dividends?

    No, Coherus Oncology, Inc. does not pay dividends

    What sector is Coherus Oncology, Inc. in?

    Coherus Oncology, Inc. is in the Healthcare sector

    What industry is Coherus Oncology, Inc. in?

    Coherus Oncology, Inc. is in the Biotechnology industry

    What country is Coherus Oncology, Inc. based in?

    Coherus Oncology, Inc. is headquartered in United States

    When did Coherus Oncology, Inc. go public?

    Coherus Oncology, Inc.'s initial public offering (IPO) was on November 6, 2014

    Is Coherus Oncology, Inc. in the S&P 500?

    No, Coherus Oncology, Inc. is not included in the S&P 500 index

    Is Coherus Oncology, Inc. in the NASDAQ 100?

    No, Coherus Oncology, Inc. is not included in the NASDAQ 100 index

    Is Coherus Oncology, Inc. in the Dow Jones?

    No, Coherus Oncology, Inc. is not included in the Dow Jones index

    When was Coherus Oncology, Inc.'s last earnings report?

    Coherus Oncology, Inc.'s most recent earnings report was on May 8, 2025

    When does Coherus Oncology, Inc. report earnings?

    The next expected earnings date for Coherus Oncology, Inc. is August 7, 2025
    On this page